Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emiko Sano

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Genetics|September 1, 2014
Plasmid copy number underlies adaptive mutability in bacteriaEmiko Sano, Sophie Maisnier-Patin, John Paul Aboubechara, et al.
International Journal of Oncology|June 11, 2009
Effect of IFN-beta on human glioma cell lines with temozolomide resistanceAtsuo Yoshino, Akiyoshi Ogino, Kazunari Yachi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 11, 2021
Interleukin-6 sensitizes TNF-α and TRAIL/Apo2L dependent cell death through upregulation of death receptors in human cancer cellsEmiko Sano, Akira Kazaana, Hisashi Tadakuma, et al.
Oncology Reports|October 23, 2019
IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cellsSodai Yoshimura, Emiko Sano, Yuya Hanashima, et al.
International Journal of Oncology|March 14, 2019
Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagyKotaro Makita, Hiroyuki Hara, Emiko Sano, et al.
Oncology Reports|October 25, 2022
Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cellsChihiro Yagi, Juri Tatsuoka, Emiko Sano, et al.
Biochemical and Biophysical Research Communications|February 10, 2020
Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cellsYoshinari Ozawa, Shun Yamamuro, Emiko Sano, et al.
International Journal of Oncology|May 9, 2015
Characterization of glioma stem-like cells from human glioblastomasShun Yamamuro, Yutaka Okamoto, Emiko Sano, et al.
International Journal of Oncology|April 30, 2010
Gene expression profiling predicts response to temozolomide in malignant gliomasAtsuo Yoshino, Akiyoshi Ogino, Kazunari Yachi, et al.
International Journal of Oncology|August 2, 2011
Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomasAtsuo Yoshino, Shinya Tashiro, Akiyoshi Ogino, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Genetics|September 1, 2014
Plasmid copy number underlies adaptive mutability in bacteriaEmiko Sano, Sophie Maisnier-Patin, John Paul Aboubechara, et al.
International Journal of Oncology|June 11, 2009
Effect of IFN-beta on human glioma cell lines with temozolomide resistanceAtsuo Yoshino, Akiyoshi Ogino, Kazunari Yachi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 11, 2021
Interleukin-6 sensitizes TNF-α and TRAIL/Apo2L dependent cell death through upregulation of death receptors in human cancer cellsEmiko Sano, Akira Kazaana, Hisashi Tadakuma, et al.
Oncology Reports|October 23, 2019
IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cellsSodai Yoshimura, Emiko Sano, Yuya Hanashima, et al.
International Journal of Oncology|March 14, 2019
Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagyKotaro Makita, Hiroyuki Hara, Emiko Sano, et al.
Oncology Reports|October 25, 2022
Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cellsChihiro Yagi, Juri Tatsuoka, Emiko Sano, et al.
Biochemical and Biophysical Research Communications|February 10, 2020
Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cellsYoshinari Ozawa, Shun Yamamuro, Emiko Sano, et al.
International Journal of Oncology|May 9, 2015
Characterization of glioma stem-like cells from human glioblastomasShun Yamamuro, Yutaka Okamoto, Emiko Sano, et al.
International Journal of Oncology|April 30, 2010
Gene expression profiling predicts response to temozolomide in malignant gliomasAtsuo Yoshino, Akiyoshi Ogino, Kazunari Yachi, et al.
International Journal of Oncology|August 2, 2011
Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomasAtsuo Yoshino, Shinya Tashiro, Akiyoshi Ogino, et al.
Pageof 3